| Primary |
| Gastrooesophageal Reflux Disease |
20.6% |
| Dyspepsia |
14.7% |
| Gastritis |
5.9% |
| Hypertension |
5.9% |
| Hypothyroidism |
5.9% |
| Palpitations |
5.9% |
| Anticoagulant Therapy |
2.9% |
| Drug Therapy |
2.9% |
| Duodenal Ulcer |
2.9% |
| Gastric Ulcer |
2.9% |
| Gastrinoma |
2.9% |
| Gout |
2.9% |
| Hiv Infection |
2.9% |
| Irritable Bowel Syndrome |
2.9% |
| Menorrhagia |
2.9% |
| Muscle Relaxant Therapy |
2.9% |
| Pain |
2.9% |
| Peptic Ulcer |
2.9% |
| Polymyalgia Rheumatica |
2.9% |
| Prophylaxis |
2.9% |
|
| Nausea |
12.0% |
| Drug Interaction |
8.0% |
| Eosinophilia |
8.0% |
| Urticaria |
8.0% |
| Anaphylactic Shock |
4.0% |
| Chest Discomfort |
4.0% |
| Diarrhoea |
4.0% |
| Drug Ineffective |
4.0% |
| Flatulence |
4.0% |
| Haematochezia |
4.0% |
| Hepatic Necrosis |
4.0% |
| Hip Arthroplasty |
4.0% |
| Idiopathic Thrombocytopenic Purpura |
4.0% |
| Iron Deficiency |
4.0% |
| Rash |
4.0% |
| Respiratory Arrest |
4.0% |
| Supraventricular Tachycardia |
4.0% |
| Swollen Tongue |
4.0% |
| Throat Tightness |
4.0% |
| Upper Limb Fracture |
4.0% |
|
| Secondary |
| Gastrooesophageal Reflux Disease |
42.2% |
| Drug Use For Unknown Indication |
24.4% |
| Hypothyroidism |
8.9% |
| Palpitations |
8.9% |
| Gastric Ulcer |
4.4% |
| Pain |
4.4% |
| Drug Therapy |
2.2% |
| Gastritis |
2.2% |
| Muscle Relaxant Therapy |
2.2% |
|
| Tetany |
35.3% |
| Hepatic Necrosis |
11.8% |
| Hypomagnesaemia |
11.8% |
| Hypoparathyroidism |
11.8% |
| Vomiting |
11.8% |
| Swollen Tongue |
5.9% |
| Upper Limb Fracture |
5.9% |
| Urine Odour Abnormal |
5.9% |
|
| Concomitant |
| Drug Use For Unknown Indication |
45.4% |
| Rheumatoid Arthritis |
8.4% |
| Hypertension |
5.5% |
| Prophylaxis |
5.3% |
| Pain |
4.9% |
| Osteoporosis |
4.6% |
| Peripheral T-cell Lymphoma Unspecified |
3.2% |
| Asthma |
2.5% |
| Colitis Ulcerative |
2.5% |
| Crohn's Disease |
2.5% |
| Depression |
2.1% |
| Diabetes Mellitus |
2.1% |
| Arthralgia |
1.5% |
| Gastric Disorder |
1.5% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Infection Prophylaxis |
1.5% |
| Cardiac Failure Congestive |
1.3% |
| Mineral Supplementation |
1.3% |
| Multiple Myeloma |
1.3% |
| Nausea |
1.3% |
|
| Pneumonia |
10.7% |
| Renal Impairment |
8.0% |
| Death |
6.7% |
| Sepsis |
6.7% |
| Thrombocytopenia |
6.7% |
| Vomiting |
6.7% |
| Wheezing |
6.7% |
| Pulmonary Infarction |
5.3% |
| Renal Failure Acute |
5.3% |
| Anti-neutrophil Cytoplasmic Antibody Positive Vasculitis |
4.0% |
| Diarrhoea |
4.0% |
| Haemothorax |
4.0% |
| Ocular Hyperaemia |
4.0% |
| Surgery |
4.0% |
| Tremor |
4.0% |
| Bone Marrow Failure |
2.7% |
| Cerebrovascular Accident |
2.7% |
| Colitis Ulcerative |
2.7% |
| Exfoliative Rash |
2.7% |
| Hallucination |
2.7% |
|
